Cognition Therapeutics Inc [CGTX] stock prices are up 7.95% to $0.32 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CGTX shares have gain 6.52% over the last week, with a monthly amount glided 2.19%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cognition Therapeutics Inc [NASDAQ: CGTX] stock has seen the most recent analyst activity on December 19, 2024, when B. Riley Securities upgraded its rating to a Buy and also boosted its price target to $1.50 from $1. Previously, Cantor Fitzgerald downgraded its rating to Neutral on July 30, 2024. On November 03, 2021, Oppenheimer initiated with a Outperform rating and assigned a price target of $22 on the stock. B. Riley Securities started tracking the stock assigning a Buy rating and suggested a price target of $27 on November 03, 2021.
The stock price of Cognition Therapeutics Inc [CGTX] has been fluctuating between $0.22 and $2.54 over the past year. Cognition Therapeutics Inc [NASDAQ: CGTX] shares were valued at $0.32 at the most recent close of the market.
Analyzing the CGTX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.42, Equity is -1.94 and Total Capital is -4.27. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.04.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.3003 points at the first support level, and at 0.2785 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.3334, and for the 2nd resistance point, it is at 0.3447.
Ratios To Look Out For
It’s worth pointing out that Cognition Therapeutics Inc [NASDAQ:CGTX]’s Current Ratio is 2.09. Also, the Quick Ratio is 2.09, while the Cash Ratio stands at 1.5.
Transactions by insiders
Recent insider trading involved Ricciardi Lisa, CEO & President, that happened on Jan 31 ’25 when 38851.0 shares were purchased.
